Wavefront abberations come in good, bad and ugly varieties

Article

While smooth wavefronts are to be preferred, some abberations may be beneficial and further study is need to identify them, said Jos Rozema, MD, of University Hospital Antwerp, Belgium.

While smooth wavefronts are to be preferred, some abberations may be beneficial and further study is need to identify them, said Jos Rozema, MD, of University Hospital Antwerp, Belgium.

Characterising wavefront varieties as the good, the bad and the 'downright' ugly, Dr Rozema noted that some higher order aberrations (HOAs) may improve vision. Studies by Schalhorn and McLellan in 2000 and 2002, respectively, revealed that US Navy pilots who require excellent vision often demonstrate HOAs, for example trefoil and Polychromiatic MTF (modulation transfer function) is usually better in mildly aberrated eyes.

Furthermore, eyes that are too corrected can suffer from reduced depth of focus, postoperative floaters and chromatic distortions after intraocular lens (IOL) implantation. "A good wavefront features regular myopia or hyperopia, or regular astigmatism, while emmetropia with minor HOAs is the ideal," said Dr Rozema. "There is an absence of lower order aberrations."

"Bad wavefronts contain a large amount of any aberration geometry and demonstrate steep wavefront slopes, making them difficult to correct by means of spectacles or contact lenses," he said.

Ugly wavefronts contain large amounts of 'micro aberrations' which are below the spatial resolution of aberrometers, and rough wavefronts are impossible to correct by conventional means. "This is usually an unintended surgical result," said Dr Rozema.

Ugly wavefronts are particularly challenging. Dr. Rozema referred one 29 year-old female patient who will need a corneal transplant to repair the damage caused by four LASIK procedures and an Intacts implantation.

Dr Rozema concluded that futher study is required to establish benchmarks identifying abberations and their impact on the quality of vision.

Ophthalmology Times Europe reporting from the XXIV Congress of the ESCRS, London, 9-13 September, 2006.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
© 2025 MJH Life Sciences

All rights reserved.